Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF). How does the rate of ...
Pooled TETON‑1/2 trials met the primary endpoint, demonstrating significantly less 52‑week FVC loss with inhaled treprostinil than placebo. Efficacy signals extended to secondary outcomes, reducing ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Oral nerandomilast doses of 9 mg and 18 mg were ...
Spirometry is a standard test doctors use to determine how well your lungs function. A score that measures airflow into and out of your lungs can help diagnose COPD and determine the best treatments.
SAN FRANCISCO — The investigational oral agent nerandomilast was superior to placebo at slowing the decline in forced vital capacity (FVC) among patients with progressive pulmonary fibrosis (PF), ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Two differing doses of deupirfenidone were assessed ...
SALT LAKE CITY--(BUSINESS WIRE/AETOSWire)-- ClearOne (NASDAQ: CLRO), a global market leader in conferencing, collaboration, and network streaming solutions, today announced the appointment of FVC, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results